380 filings
Page 8 of 19
8-K
9et h0aemk4ah
5 Jun 15
Other Events
12:00am
8-K
c5uamlgns65gg ijdk0m
13 Apr 15
Other Events
12:00am
8-K
4shldusv6fm3jnk jtjl
16 Mar 15
ARCA Biopharma provides genetic-af clinical trial update
12:00am
8-K
776j3 9wn
23 Feb 15
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
i3bte1epb674 ylyxq1n
17 Feb 15
Departure of Directors or Certain Officers
12:00am
8-K
vi33b5bb0txqy79
4 Feb 15
Other Events
12:00am
8-K/A
d9p9tl3t
30 Dec 14
Departure of Directors or Certain Officers
12:00am
8-K
mfeue
11 Dec 14
Arca Biopharma Announces Activation of First Canadian
12:00am
8-K
rfakj a0tv1bcwbnpb
10 Dec 14
Arca Biopharma Receives Fda Orphan Drug Designation for RNAPC2 As a Potential Treatment for Ebola
12:00am
8-K
35zh6088pskcr
1 Dec 14
Arca Biopharma Announces Management Transitions
12:00am
8-K
lv18 pyxiy6nwh
18 Aug 14
Arca Biopharma Announces Health Canada Acceptance of Genetic-af Clinical Trial Application
12:00am
8-K
rr395qkb488cku8
9 Jun 14
Robert E. Conway Elected Chairman of Arca Biopharma
12:00am
8-K
9haho e22y5l
3 Mar 14
Departure of Directors or Certain Officers
12:00am
8-K
xprdnv9wb3 is799c9c
18 Feb 14
Departure of Directors or Certain Officers
12:00am
8-K
5npoirj
12 Feb 14
Dan Mitchell Joins Arca Biopharma Board of Directors
12:00am
8-K/A
8nteug6bm
10 Feb 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
9qvuju1
4 Feb 14
Arca Biopharma Announces Proposed Public Offering of Common Stock and Warrants
12:00am
8-K
2nm8m13ufzk0st v4coz
8 Jan 14
Arca Biopharma to Present at Biotech Showcase 2014
12:00am
8-K
tltfnm ih
5 Dec 13
Arca Biopharma Announces Us Fda Acceptance of Gencaro Ind
12:00am
8-K
17ak5ax6
21 Nov 13
Arca Biopharma Announces Resignation from Board of Directors
12:00am